Tonya J. Webb

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Lee MS, Webb TJ. (2023) Novel lipid antigens for NKT cells in cancer. Frontiers in Immunology. 14: 1173375
Kratzmeier C, Singh S, Asiedu EB, et al. (2022) Current Developments in the Preclinical and Clinical use of Natural Killer T cells. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 1-15
Cairo C, Webb TJ. (2022) Effective Barriers: The Role of NKT Cells and Innate Lymphoid Cells in the Gut. Journal of Immunology (Baltimore, Md. : 1950). 208: 235-246
Webb TJ. (2021) Inclusion criteria: how NK cells gain access to T cells. The Journal of Clinical Investigation. 131
Ingram Z, Madan S, Merchant J, et al. (2021) Targeting Natural Killer T Cells in Solid Malignancies. Cells. 10
Shissler SC, Bates JP, Hester D, et al. (2021) Inbred Strain Characteristics Impact the NKT Cell Repertoire. Immunohorizons. 5: 147-156
Webb TJ, Yuan W, Meyer E, et al. (2020) Editorial: NKT Cells in Cancer Immunotherapy. Frontiers in Immunology. 11: 1314
Shissler SC, Singh NJ, Webb TJ. (2020) Thymic resident NKT cell subsets show differential requirements for CD28 co-stimulation during antigenic activation. Scientific Reports. 10: 8218
Lee MS, Sun W, Webb TJ. (2020) Sphingosine Kinase Blockade Leads to Increased Natural Killer T Cell Responses to Mantle Cell Lymphoma. Cells. 9
Humeniuk P, Geiselhart S, Battin C, et al. (2019) Publisher Correction: Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Scientific Reports. 9: 16382